Lash Serum Ingredients to Avoid
An exact-name label guide with source-dated product examples and clear evidence limits.
The short answer
Use an exact-name label screen, not a suffix rule or a universal “safe/unsafe” score. The strongest reason to pause is a current label that lists a named prostaglandin analogue or a prescription drug ingredient in a non-prescription product. Fragrance, alcohol, and preservatives are different questions: they may matter for tolerability, but their presence alone does not establish that a finished formula is dangerous.
Start with the product label directory, then paste the ingredient list from your exact package into the bounded ingredient checker. No match is not a safety grade.
Exact names to check
Do not classify an ingredient from the fragments prost, prostenol, or prostamide alone. Compare the full INCI name with a dated authority or product label.
Scrollable table: swipe left to see every column →
| Name | What a match establishes | What it does not establish |
|---|---|---|
| Isopropyl cloprostenate | The reviewed label lists the exact cosmetic analogue assessed by SCCS and named by Health Canada. | The product concentration, individual risk, or finished-formula efficacy. |
| Dechloro dihydroxy difluoro ethylcloprostenolamide (DDDE) | The reviewed label lists an exact analogue assessed in the 2026 SCCS opinion. | That every market or later package uses the same formula. |
| Methylamido dihydro noralfaprostal (MDN) | The reviewed label lists an exact analogue assessed in the 2026 SCCS opinion. | A class-wide result for unrelated names. |
| Bimatoprost | LATISSE uses prescription bimatoprost 0.03% under a drug label. | That an over-the-counter cosmetic can make the same claims or use the drug outside clinical supervision. |
Why these exact names matter: the SCCS final opinion adopted February 2, 2026 concluded that IPCP, MDN, and DDDE could not be considered safe for cosmetic products intended to promote eyelash or eyebrow growth under the assessed conditions. It cited their potent pharmacological activity and unresolved reproductive and developmental toxicity concerns. That is an expert safety opinion, not shorthand for every compound, formula, jurisdiction, or user. Health Canada's current Hotlist separately prohibits prostaglandins, their salts, derivatives, and analogues in cosmetics.
Prescription bimatoprost has a different evidence and regulatory context. The FDA-approved LATISSE label warns about effects including increased iris pigmentation, eyelid skin darkening, hair growth outside the treatment area, and eye irritation. Those drug-label warnings should not be converted into product-specific rates for unrelated cosmetic serums.
Tolerability flags are not the same as prostaglandin classification
Added fragrance, denatured alcohol, and some preservatives can matter to people with a history of eye-area irritation or contact allergy. Ingredient order alone does not reveal the exact concentration, and a label cannot predict who will react. If a product stings, causes persistent redness, swelling, pain, vision changes, or a worsening rash, stop using it and seek appropriate clinical advice.
Conditioning ingredients such as oils, panthenol, or proteins may change softness, shine, or breakage. Their presence does not prove follicle growth. That is an effectiveness-evidence question, not a reason to call the ingredient unsafe.
For adjacent decisions, see our guides to lash serum side effects, serums for sensitive eyes, peptide lash serums, Vaseline and lash growth, and castor oil versus lash serum.
Dated product-label examples
Formulas change, so the product name is not the evidence. The current product label directory records the exact name, date, and review page for each label we have checked.
Scrollable table: swipe left to see every column →
| Product | Reviewed label finding | Full evidence |
|---|---|---|
| GrandeLASH-MD | Isopropyl cloprostenate listed. | GrandeLASH review |
| RapidLash | Isopropyl cloprostenate identified in the photographed insert. | RapidLash review |
| RevitaLash Advanced | DDDE listed on the dated label reviewed. | RevitaLash review |
| The Ordinary Multi-Peptide Lash & Brow Serum | No exact name from the bounded covered list found on the reviewed label. | The Ordinary review |
More dated examples are available in our reviews of NeuLash, Babe Original, LATISSE, SOWN Root 1, Vegamour GRO, and LASHFOOD.
How to screen a lash serum label
- Use the current box or complete official market-specific ingredient list.
- Keep each INCI name intact; do not shorten long names.
- Run the list through the ingredient checker.
- Open the matching ingredient page and product review for source scope.
- Recheck the package date and market. A prior label is not proof of the current formula.
Frequently asked questions
What ingredients should I avoid in lash serum?
There is no universal list for every person. A current label that matches a named prostaglandin analogue is a strong reason to review the exact ingredient evidence and your own eye-health context. People with irritation or allergy histories may also choose to avoid fragrance or alcohol-heavy formulas, but label presence alone is not a diagnosis.
Does GrandeLASH contain a prostaglandin analogue?
The dated GrandeLASH-MD label we reviewed lists isopropyl cloprostenate. Check the current package because formulas can change.
Does RapidLash contain a prostaglandin analogue?
The photographed RapidLash insert reviewed by The Lash List identifies isopropyl cloprostenate as a synthetic prostaglandin analogue. That finding is tied to the photographed package and date.
Does RevitaLash contain a prostaglandin analogue?
The dated RevitaLash Advanced label we reviewed lists DDDE. Confirm the exact market and package before applying that answer to another bottle.
What should I use instead?
Choose by your label preference, tolerability needs, budget, and the strength of finished-formula evidence. Our prostaglandin-free guide compares current labels without claiming that “free from” automatically means safe or effective.